Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
1.050
-0.020 (-1.87%)
At close: Oct 9, 2025, 4:00 PM EDT
1.025
-0.025 (-2.38%)
Pre-market: Oct 10, 2025, 8:44 AM EDT

Applied Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
0.120.469.99---
Upgrade
Revenue Growth (YoY)
-89.08%-95.45%----
Upgrade
Gross Profit
0.120.469.99---
Upgrade
Selling, General & Admin
67.2356.0120.6227.3243.0532.68
Upgrade
Research & Development
44.2848.7453.9155.6362.5761.79
Upgrade
Total Operating Expenses
111.51104.7574.5382.95105.6294.47
Upgrade
Operating Income
-111.39-104.3-64.54-82.95-105.62-94.47
Upgrade
Interest Income
3.313.531.370.690.56-
Upgrade
Other Non-Operating Income (Expense)
40.35-4.86-56.6-0.24-0.520.51
Upgrade
Total Non-Operating Income (Expense)
43.65-1.33-55.230.440.030.51
Upgrade
Pretax Income
-67.74-105.62-119.76-82.51-105.58-93.96
Upgrade
Net Income
-67.74-105.62-119.76-82.51-105.58-93.96
Upgrade
Net Income to Common
-67.74-105.62-119.76-82.51-105.58-93.96
Upgrade
Shares Outstanding (Basic)
14514084382622
Upgrade
Shares Outstanding (Diluted)
14314084382622
Upgrade
Shares Change (YoY)
18.99%65.63%122.72%47.77%16.53%71.19%
Upgrade
EPS (Basic)
-0.41-0.76-1.42-2.18-4.12-4.28
Upgrade
EPS (Diluted)
-0.26-0.76-1.42-2.18-4.12-4.28
Upgrade
Free Cash Flow
-91.78-84.31-55.17-78.09-90.73-78.21
Upgrade
Free Cash Flow Per Share
-0.64-0.60-0.65-2.06-3.54-3.56
Upgrade
Gross Margin
100.00%100.00%100.00%---
Upgrade
Operating Margin
-92057.02%-22922.86%-645.80%---
Upgrade
Profit Margin
-55982.64%-23214.07%-1198.47%---
Upgrade
FCF Margin
-75847.93%-18528.57%-552.12%---
Upgrade
EBITDA
-111.2-103.31-62.07-78.92-105.2-91.53
Upgrade
EBITDA Margin
-91904.13%-22704.84%-621.13%---
Upgrade
EBIT
-111.39-104.3-64.54-82.95-105.62-94.47
Upgrade
EBIT Margin
-92057.02%-22922.86%-645.80%---
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q